| FDA User Fee Table | FY2023 Fee Rate | FY2022 Fee Rate | Change | Percent Change |
| Prescription Drug User Fee Amendment (PDUFA VII) | ||||
| Application requiring clinical Data | $3,242,026 | $3,117,218 | $124,808 | 4% |
| Application not requiring clinical data | $1,621,013 | $1,558,609 | $62,404 | 4% |
| Program Fee | $393,933 | $369,413 | $24,520 | 7% |
| Generic Drug User Fee Amendment (GDUFA III) | ||||
| Abbreviated new drug application (ANDA) | $240,582 | $225,712 | $14,870 | 7% |
| Drug master file (DMF) | $78,293 | $74,952 | $3,341 | 4% |
| Facility: | ||||
| Active pharmaceutical ingredient (API) – Domestic | $37,544 | $42,557 | -$5,013 | -12% |
| API – Foreign | $52,544 | $57,557 | -$5,013 | -9% |
| Finished dosage form (FDF) – Domestic | $213,134 | $195,012 | $18,122 | 9% |
| FDF – Foreign | $228,134 | $210,012 | $18,122 | 9% |
| Contract manufacturing organization (CMO) – Domestic | $51,152 | $65,004 | -$13,852 | -21% |
| CMO – Foreign | $66,152 | $80,004 | -$13,852 | -17% |
| GDUFA program: | ||||
| Large size operation generic drug applicant | $1,620,556 | $1,536,856 | $83,700 | 5% |
| Medium size operation generic drug applicant | $648,222 | $614,742 | $33,480 | 5% |
| Small business operation generic drug applicant | $162,056 | $153,686 | $8,370 | 5% |
| Biosimilar User Fee Amendment (BSUFA III) | ||||
| Initial biological product development (BPD) | $47,325 | $57,184 | -$9,859 | -17% |
| Annual BPD | $47,325 | $57,184 | -$9,859 | -17% |
| Reactivation | $94,650 | $114,368 | -$19,718 | -17% |
| Applications requiring clinical data | $1,746,745 | $1,746,745 | $0 | 0% |
| Applications not requiring clinical data | $873,373 | $873,373 | $0 | 0% |
| Program | $304,162 | $304,162 | $0 | 0% |
| Medical Device User Fee Amendment (MDUFA V) | ||||
| Premarket approval (PMA) or Biologics License Application (BLA) standard fee | $441,547 | $374,858 | $66,689 | 18% |
| Premarket approval (PMA) or Biologics License Application (BLA) small business fee | $110,387 | $93,714 | $16,673 | 18% |
| Premarket report standard fee | $441,547 | $374,858 | $66,689 | 18% |
| Premarket report small business fee | $110,387 | $93,714 | $16,673 | 18% |
| Efficacy supplement to an approved BLA standard fee | $441,547 | $374,858 | $66,689 | 18% |
| Efficacy supplement to an approved BLA small business fee | $110,387 | $93,714 | $16,673 | 18% |
| Panel-track supplement standard fee | $353,238 | $281,143 | $72,095 | 26% |
| Panel-track supplement small business fee | $88,309 | $70,286 | $18,023 | 26% |
| De novo classification request standard fee | $132,464 | $112,457 | $20,007 | 18% |
| De novo classification request small business fee | $33,116 | $28,114 | $5,002 | 18% |
| 180-day supplement standard fee | $66,232 | $56,229 | $10,003 | 18% |
| 180-day supplement small business fee | $16,558 | $14,057 | $2,501 | 18% |
| Real-time supplement standard fee | $30,908 | $26,240 | $4,668 | 18% |
| Real-time supplement small business fee | $7,727 | $6,560 | $1,167 | 18% |
| 510(k) standard fee | $19,870 | $12,745 | $7,125 | 56% |
| 510(k) small business fee | $4,967 | $3,186 | $1,781 | 56% |
| 30-day notice standard fee | $7,065 | $5,998 | $1,067 | 18% |
| 30-day notice small business fee | $3,532 | $2,999 | $533 | 18% |
| 513(g) request for classification information standard fee | $5,961 | $5,061 | $900 | 18% |
| 513(g) request for classification information small business fee | $2,980 | $2,530 | $450 | 18% |
| Annual fee for periodic reporting on a Class III device standard fee | $15,454 | $13,120 | $2,334 | 18% |
| Annual fee for periodic reporting on a Class III device small business fee | $3,864 | $3,280 | $584 | 18% |
| Annual establishment registration fee standard fee | $6,493 | $5,672 | $821 | 14% |
| Annual establishment registration fee small business fee | $6,493 | $5,672 | $821 | 14% |